MCKESSON CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 561.5 USD | +0.29% |
|
+5.03% | +21.01% |
| May. 09 | Deutsche Bank Adjusts Price Target on McKesson to $545 From $547 | MT |
| May. 09 | Wells Fargo Adjusts Price Target on McKesson to $551 From $502 | MT |
ETFs positioned on McKesson Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 3 M€ | +5.91% | - | |
| 0.01% | 6 M€ | -4.26% | - | |
| 0.00% | 11 M€ | +1.95% | - | |
| 0.01% | 34 M€ | +3.77% | - | |
| 4.84% | 129 M€ | +6.62% | - |
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (87%);
- distribution of medical and surgical products (4%);
- other (1.6%): primarily technology services and software sales.
The remaining net sales (7.4%) are from international activities.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
559.9
USD
Average target price
579.9
USD
Spread / Average Target
+3.57%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +21.01% | 72.78B | |
| -1.92% | 24.24B | |
| +8.80% | 8.59B | |
| +9.15% | 8.38B | |
| -17.39% | 8.09B | |
| +7.33% | 4.81B | |
| +17.69% | 4.32B | |
| -3.66% | 4.05B | |
| -2.82% | 3.93B | |
| +29.14% | 3.79B |
- Stock Market
- Equities
- MCK Stock
- Funds and ETFs McKesson Corporation